KDM1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.258000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.896000E-01
Normal-vs-Stage2
4.158400E-01
Normal-vs-Stage3
7.329800E-02
Normal-vs-Stage4
6.838000E-01
Stage1-vs-Stage2
9.974200E-01
Stage1-vs-Stage3
1.285610E-01
Stage1-vs-Stage4
1.601380E-01
Stage2-vs-Stage3
1.610810E-01
Stage2-vs-Stage4
1.380570E-01
Stage3-vs-Stage4
2.883600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.334200E-01
Normal-vs-AfricanAmerican
7.052600E-01
Normal-vs-Asian
2.399400E-01
Caucasian-vs-AfricanAmerican
7.002400E-01
Caucasian-vs-Asian
4.851200E-01
AfricanAmerican-vs-Asian
3.267800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.876800E-01
Normal-vs-Female
4.541200E-01
Male-vs-Female
8.048200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.940800E-01
Normal-vs-Age(41-60Yrs)
5.574400E-01
Normal-vs-Age(61-80Yrs)
5.347600E-01
Normal-vs-Age(81-100Yrs)
4.284400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.820800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.487000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.997200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.722400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.917600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.968400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.077200E-01
Normal-vs-Daily Drinker
5.169600E-02
Normal-vs-Weekly Drinker
2.198200E-01
Normal-vs-Occasional Drinker
8.737000E-01
Normal-vs-Social Drinker
9.820800E-01
Non Drinker-vs-Daily Drinker
7.795800E-02
Non Drinker-vs-Weekly Drinker
9.608400E-01
Non Drinker-vs-Occasional Drinker
1.561200E-01
Non Drinker-vs-Social Drinker
1.006960E-01
Daily Drinker-vs-Weekly Drinker
1.262350E-01
Daily Drinker-vs-Occasional Drinker
1.578480E-02
Daily Drinker-vs-Social Drinker
1.212290E-02
Weekly Drinker-vs-Occasional Drinker
1.945410E-01
Weekly Drinker-vs-Social Drinker
1.248000E-01
Occasional Drinker-vs-Social Drinker
7.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.267000E-01
Normal-vs-Grade 2
5.800000E-02
Normal-vs-Grade 3
3.081800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.526800E-01
Grade 1-vs-Grade 3
9.396400E-01
Grade 1-vs-Grade 4
2.267000E-01
Grade 2-vs-Grade 3
4.852800E-01
Grade 2-vs-Grade 4
5.800000E-02
Grade 3-vs-Grade 4
3.081800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.033200E-01
Normal-vs-NonDiabetic
4.951400E-01
Diabetic-vs-NonDiabetic
7.834800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.821900E-02
Normal-vs-NoPancreatitis
5.713800E-01
Pancreatitis-vs-NoPancreatitis
7.258100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.636800E-01
Normal-vs-N1
4.116200E-01
N0-vs-N1
3.721800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.931600E-01
Normal-vs-TP53-NonMutant
8.612200E-01
TP53-Mutant-vs-TP53-NonMutant
2.286200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
